Catabolism of lean body mass (particularly muscle) occurs in sepsis and other forms of critical illness despite apparently adequate nutritional support. The determination of the optimal balance of carbohydrate and fat intake in this circumstance should be based on the resulting effect on the maintenance of lean body mass, and the nature and extent of any side effects. The general stress response involves a disruption in normal glucoregulation, in that hepatic glucose production is accelerated and the normal blood glucose lowering action of insulin is diminished. Nonetheless, the capacity to oxidize glucose once inside the cells is not impaired. Lipolysis, or the breakdown of peripheral triglycerides to free fatty acids (FFA) and glycerol, is accelerated in critical illness, to a greater extent than fat oxidation. Provision of exogenous fat maintains fat stores, but has minimal effect on the direct oxidation of plasma FFA. From the results of oxidation studies, it seems that about 5 mg kgÁmin of glucose can be readily oxidized, and the balance of energy will be supplied by the oxidation of fat, either endogenous or exogenous. However, an additional consideration in determining the optimal caloric substrate is that insulin is a potent anabolic hormone and stimulates muscle protein synthesis. Consequently, provision of exogenous insulin enhances retention of muscle. This procedure dictates that almost all non-protein calories be provided as carbohydrate to avoid hypoglycemia. Preliminary studies suggest this may be the optimal approach in critically ill patients. Glucose and fatty acids are the major energy substrates in the body. The oxidative metabolism of these substrates provides the ATP needed for physiological function, including protein synthesis. Over the past 20 y, development of new techniques in nutritional support have made it possible to provide large amounts of carbohydrate and fat to critically-ill patients, along with protein or amino acids. However, despite providing such patients with what should be more than adequate caloric and protein intake, critically ill patients lose lean body mass (Streat et al, 1987) , largely because of persistent muscle catabolism (Sakurai et al, 1995) . The general relation between energy substrate metabolism and maintenance of lean body mass has been recognized for many years (Calloway & Spector, 1954) , so it is important to examine the alterations in energy substrate metabolism that occur in response to critical illness that may play a role in causing the persistent catabolism of muscle protein.
Is there a generalized metabolic response to stress?
The notion of a`stress response' has been considered for more than 50 y, and there is no doubt that all forms of critical illness have certain common responses that could be called a generalized stress response. However, when discussing speci®c responses of carbohydrate and fat metabolism, it is pertinent to examine this question in more detail. This is because much of the research in this area has been performed in severely burned patients. Burn injury is a good model of stress, because the exact extent of injury can be quanti®ed, and patients are often in a stable (but critical) state for weeks. However, it is important to know if the responses in severely burned patients are applicable to other critically-ill patients, particularly patients with sepsis. Figure 1 summarizes results of several studies in which glucose production has been quanti®ed in the post-absorptive state and during the infusion of glucose. When compared to normal control values, the rate of glucose production is elevated in all forms of critical illness, including both burns and sepsis. Furthermore, the normal suppressive effect of infused glucose on endogenous glucose production is diminished in patients. Therefore, although the magnitude of response may differ in different circumstances, it is reasonable to consider a general stress response of glucose production, and to extrapolate from results in burn patients to other causes for critical illness. This is also the case for glucose uptake, which will be discussed in more detail below.
The rate of hydrolysis of triglyceride, or lipolysis, has not been measured in as many circumstances as has glucose production. Nonetheless the ®ndings have consistently revealed increased rates of lipolysis in critically ill patients (Figure 2 ), again suggesting a common stress response. Also, increased concentrations of fatty acids and triglycerides are common in all forms of critical illness (Gallin et al, 1969; Aarsland et al, 1996b) . Taken together with the ®ndings regarding glucose production, it is reasonable to suggest a common response of substrate metabolism to stress. It is likely the stress hormones (glucagon, cortisol and catecholamines) are largely responsible for the alterations in substrate metabolism. Although the stimulus for the release of these hormones is not always clear, it is possible that bacteria or endotoxin play a role in all forms of critical illness. Therefore, it has recently been shown that endotoxin concentrations rose signi®cantly in severely burned patients (Kelly et al, 1997) . This could arise from bacterial translocation from the gut (Maejima et al, 1984) . Regardless of the mechanisms responsible, from the practical standpoint of determining optimal nutrition, it is reasonable to consider the responses of substrate metabolism to critical illness to be roughly similar.
Glucose production
Under normal circumstances, many physiological control mechanisms ensure that there is a relatively close matching of the uptake of glucose by the tissues and the appearance of glucose in the bloodstream. This matching of uptake and appearance, re¯ected by a relatively constant blood glucose concentration over a wide range of circumstances, is controlled by regulatory factors governing both uptake and production.
There are two components of glucose production: glycogenolysis and gluconeogenesis. Following the ingestion of a meal or during a glucose infusion, a signi®cant portion of the exogenous glucose ends up stored as glycogen in the liver. Glycogen exerts a negligible osmotic pressure and can be degraded on demand. Glycogen is stored in the liver when glucose is abundant (such as immediately after a meal) and released into the circulation during fasting. The exact contribution of glycogen to total glucose production is dif®cult to quantify, but after an overnight fast estimates range as high as 90% (Cahill, 1970) . With more prolonged fasting (60 h), hepatic glycogen becomes depleted and gluconeogenesis becomes the entire source of glucose production.
Gluconeogenesis is the new formation of glucose from noncarbohydrate precursors. Lactate is the single most important gluconeogenic precursor under most conditions; much of the lactate is derived from plasma glucose via glycolysis, and resynthesis of glucose from lactate is a cyclic process. Alanine is the major amino acid precursor for gluconeogenesis. Far more alanine is released from muscle than is present in muscle protein. The pyruvate resulting from the peripheral glycolytic catabolism of glucose is transaminated and the resulting alanine is released into the bloodstream and travels to the liver, where the carbons are reincorporated into glucose and the N is incorporated into urea (Felig, 1973) . The ammonia group required for the transamination of pyruvate is derived from the amino acids valine, leucine, and isoleucine, as well as aspartate and glutamate. It has been proposed that the role of this process is the transfer of potentially toxic ammonia from muscle to liver in a nontoxic form.
An elevated rate of glucose production is central to the disruption of normal glucoregulation in critical illness. This is true for almost any type of critical illness, but the response has been most extensively documented in severe burn injury (Wolfe et al, 1979b) . The magnitude of increase in glucose production may vary, but in virtually all patients the value is more than two standard derivations above the normal value. Furthermore, the normal suppressive action of exogenous glucose intake on endogenous production is either diminished or completely lost in both burn and septic patients (Wolfe 1979b; Shaw & Wolfe, 1986a) . Consequently, hyperglycemia is frequently observed in patients. Whereas a component of the cause of hyperglycemia may be changes in the peripheral metabolism of glucose (see below), the excess appearance of glucose in the blood is an important contributor to hyperglycemia.
Elevated glucagon concentration is responsible for the acceleration of glucose production in patients. When the secretion of glucagon and insulin were inhibited in severely burned patients by the infusion of somatostatin, and insulin was infused to maintain the basal concentration, the accelerated rate of glucose production decreased almost to the normal range, even though the concentration of glucagon was still about double the normal value (Jahoor et al, 1986) . On the one hand, the predominant role of glucagon as a stimulator of glucose production might have been expected, based on studies in normal dogs (Cherrington et al, 1987) . On the other hand, the acute elevation of glucagon concentration caused by glucagon infusion in normal volunteers causes only a transient increase in glucose production which lasts for only an hour or two (Miyoshi et al, 1988) . In burn patients, the glucagon concentration is elevated for weeks, and yet its effectiveness in stimulating glucose production is maintained. The persistent effectiveness of glucagon on glucose production may result from an interaction with other catabolic hormones, such as epinephrine and cortisol, that are also elevated at this time. Figure 1 Rate of basal glucose production ( u) and endogenous glucose production during glucose infusion (j) in a variety of critically ill patients. Values were determined by means of the infusion of 6,6-2 H-glucose. *P`0.05 vs normal volunteers. From: Wolfe et al, 1979a,b; Shaw & Wolfe, 1986a ,b, 1987 Shaw et al, 1985 . C-palmitate. *P`0.05 vs normal volunteers. From: Wolfe et al, 1987a,b; Shaw & Wolfe, 1989; Klein et al, 1991. Sepsis as a modulator of adaptation RR Wolfe
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From the results of the study discussed above it is evident that with pharmacological treatment the rate of glucose production can be normalized in critically ill patients. However, the primary nutritional consequence of an accelerated rate of glucose production is its possible link to accelerated protein breakdown, stemming from the fact that amino acids (particularly alanine) serve as precursors for gluconeogenesis. It is therefore pertinent to consider if accelerated glucose production stimulates protein breakdown. The teleological basis for such a link would be that accelerated protein breakdown would make available more gluconeogenic precursors. In order to assess this possibility, amino acid and protein kinetics were also quanti®ed in the experiment in which insulin and glucagon concentrations were altered (Jahoor et al, 1986) . When glucagon was reduced and insulin maintained at the basal concentration, peripheral amino acid release was not signi®cantly affected. This is consistent with the observation that glucagon has only a minor, transient role on protein breakdown in normal volunteers (Hartl et al, 1990) . Consequently, the accelerated rate of glucose production is not directly linked to an increased rate of peripheral protein breakdown in burn patients. Since the effort and cost of controlling glucose production in this circumstance by hormonal manipulation cannot be justi®ed solely on the basis of better control of the plasma glucose concentration, somatostatin infusion should not be used routinely in clinical practice.
Glucose uptake
Glucose taken up by cells is either stored as glycogen or metabolized. If metabolized, the predominant route is via glycolysis, or the sequential anaerobic breakdown of glucose to pyruvate. The pyruvate produced by glycolysis can then be converted to lactate and released into the blood or be decarboxylated and enter the tricarboxylic acid (TCA) cycle for complete oxidation. For pyruvate to enter the TCA cycle, pyruvate must ®rst be transported into the mitochondria and converted to acetyl CoA. This process is catalyzed by several enzymes, collectively referred to as the pyruvate dehydrogenase complex. Once acetyl CoA is formed, it can enter the TCA cycle, where it is oxidized.
Regulation of glucose utilization
Under normal conditions glucose is the major fuel of the body after ingestion of a high carbohydrate meal. After several hours of fasting, only about 25% of total CO 2 production is from glucose oxidation (Wolfe et al, 1979) . Certain tissues, most notably the brain and erythrocytes, depend on glucose energy and have a relatively constant rate of uptake of glucose under most conditions. The liver plays an important role in the disposition of a glucose load (Felig et al, 1975) . Whereas glycogen deposition is the most prominent pathway for glucose taken up by the liver, during high rates of glucose uptake the liver can also rely on glucose oxidation as a source of energy (Baba et al, 1994) . Despite the important role of the liver, the muscle mass exerts a profound in¯uence on the overall rate of glucose utilization. Because muscle constitutes approximately 40% of the body mass, any change in the rate of glucose uptake by muscle will signi®cantly affect the overall rate of glucose uptake. In the postabsortive human at rest, it is debatable whether the muscle takes up any glucose at all (Andres et al, 1956 ), but following a meal the rate of glucose utilization by the muscle can increase severalfold. The muscle is the major site of changes in uptake kinetics in critical illness.
Muscle uptake of glucose
Glucose is rapidly phosphorylated to glucose-6-phosphate (G-6-P) once inside the cell, so the intracellular concentration of glucose is lower than the extracellular concentration, and movement of glucose into the cell occurs down its concentration gradient. Glucose diffusion is facilitated by a carrier-transport system that, when combined with glucose, renders the glucose suf®ciently lipid soluble to move through the cell membrane. Under normal conditions, the rate of glucose uptake increases in muscle as the blood level of glucose increases, and, for any blood concentrations of glucose, insulin increases the ability of the muscle cell to take up glucose.
The term`diabetes of stress' has been used for more than 50 y to describe the general clinical condition of hyperglycemia with the simultaneous elevation of insulin concentration, particularly during food intake. As discussed above, an elevated rate of glucose production is central to the disruption of normal glucoregulation in critical illness (Wolfe et al, 1979b) . Since glucose production in critical illness is not responsive to the normally suppressive effect of insulin, the liver is a major site of the insulin resistance. Nonetheless, the concept of`diabetes of stress' has classically referred to the blunted ability of insulin to stimulate peripheral (muscle and fat) glucose uptake, which is a general characteristic of diabetes. However, the basal (post-absorptive) rate of peripheral glucose clearance is generally elevated in critical illness (Wolfe et al, 1979b ). This observation is nonetheless consistent with the general notion of peripheral`insulin resistance' in critical illness, because most of glucose uptake in the basal state occurs in insulin-independent tissues (brain, erythrocytes, wound tissue). In fact, within the physiological range of insulin concentration, the hypoglycemic action of insulin is diminished in critically ill patients Black et al, 1982) . On the other hand, the maximal physiological effectiveness of insulin is not markedly reduced in severe injury , particularly if the effect of bedrest in the injured patient is considered (Stuart et al, 1988) . In contrast, in sepsis the maximal effectiveness of insulin is decreased approximately 50% below normal . The mechanism explaining the difference in magnitude of insulin resistance between sepsis and severe injury is not clear. The resistance to a physiological increase in insulin concentration has been demonstrated in a variety of experiments in injured patients. For example, when glucose was infused into severely burned patients and normal volunteers at a constant rate (4 mgakgÁmin), almost ®ve times as much insulin had to be infused into the patients as into normal volunteers in order to maintain the basal glucose concentration (Wolfe et al, 1979b) .
The nutritional implication of peripheral resistance to the hypoglycemic action of insulin is dependent on two factors. Firstly, if the`insulin resistance' is due to an inability to oxidize glucose, glucose would not be a good nutritional source. Secondly, if the resistance to the hypoglycemic action of insulin is paralleled by a resistance to the anabolic effect of insulin on protein metabolism, then any bene®cial effect of glucose intake (and the resultant insulin response) would be minimized. An impaired capacity for glucose oxidation in critical illness is suggested not only by a de®ciency in glucose clearance when insulin is elevated, but also by high blood lactate concentrations. Although cardiovascular insuf®ciency, and therefore tissue hypoxia, may be the cause of a high blood lactate concentration, in some cases lactate concentration may be elevated 4 ± 5 times above normal in a patient who appears to have adequate oxygenation, as indicated by arterial blood gases. Furthermore, infusion of dicloroacetate, which stimulates the enzyme pyruvate dehydrogenase (PDH), which decarboxylates pyruvate for conversion to acetyl CoA for entry into the TCA cycle, increases pyruvate oxidation in both burn patients and patients with sepsis Gore et al, 1996) . This response is dependent on an adequate level of tissue oxygenation. These results suggest there may be an impairment in pyruvate oxidation in critically-ill patients. However, a stable-isotope study directly quantifying pyruvate oxidation in severely burned children showed that there was no impairment. Rather, the high rate of lactate production in burn patients derives from the extraordinarily high appearance rate of pyruvate production via glycolysis. The percentage of pyruvate production that is oxidized is not altered in critically ill patients . The stimulation of glycolysis is caused in part by the rapid rate of glucose uptake from plasma. A rapid rate of plasma glucose uptake may appear to be at odds with the notion of peripheral insulin resistance. However, the rate of glucose uptake is essentially dictated by the rate of appearance of glucose into blood. It is primarily the glucose clearance rate, that is, the plasma glucose concentration at which a given amount of glucose uptake occurs, that is affected by insulin resistance. Therefore, a high rate of glucose production, both in the basal state and during glucose infusion, causes a signi®cantly greater than normal rate of glucose uptake in burn injury, regardless of the extent of insulin insensitivity. Once inside the cell, glucose is metabolized roughly the same in patients and volunteers. These results indicate that glucose should theoretically be a good energy substrate for burned patients, even though normal plasma glucoregulation is altered.
When designing nutritional support, it is necessary to move beyond the theoretical and determine a speci®c rate of carbohydrate intake. One important aspect of this determination is the rate at which ingested or infused glucose is oxidized. For this reason, glucose has been infused into burned patients at different rates in order to determine optimal rates of glucose oxidation (Wolfe et al, 1979b; Burke et al, 1979) . In sum, these studies have shown the maximal direct oxidation of glucose to occur at an infusion rate of approximately 5 mgakgÁmin. Furthermore, whereas the simultaneous infusion of insulin lowers the blood glucose at which the oxidation occurs, it does not change the maximal glucose oxidation rate (Wolfe et al, 1979a) . For a 70 kg man, this rate of glucose administration corresponds to approximately 500 g of glucose per day, or 2000 kcal. Glucose given at a rate above this will not contribute signi®cantly to the direct provision of energy, and therefore this is a reasonable limit of glucose intake to propose. However, there is an anabolic action of insulin unrelated to its effect on glucose oxidation, which will be discussed below. Also, there are alterations in fat metabolism that should also be considered when formulating nutrition support. Therefore, whereas the oxidation studies provide pertinent in®rmation, they should not necessarily be the sole determinant of the optimal rate of glucose administration.
Lipid metabolism
Catecholamines are the predominant stimulator of the hydrolysis of stored triglyceride (lipolysis) via the enzyme hormone sensitive lipase. In any stress state, including the response to injury or critical illness, sympathetic nervous system activity is markedly increased, so it is not surprising that the rate of lipolysis (as assessed either by the rate of appearance of glycerol or free fatty acids (FFA) into plasma) is markedly elevated in such patients ( Figure  2 ) (Wolfe et al, 1987a,b) . The predominant stimulus for this response is b 2 adrenergic stimulation, as in burn patients as well as septic animals, lipolysis is reduced almost to normal by the non-selective b 1 and b 2 blocker propanolol (Wolfe et al, 1987a,b; Herndon et al, 1988 ), but lipolysis is not affected by the b 1 blocker metoprolol (Herndon et al, 1994) . However, unlike the case of glucose, where the rate of metabolism is closely linked to the rate of uptake, FFA release may be completely dissociated from its rate of oxidation. Rather, fatty acids participate in what can be called the`triglyceride-fatty acid cycle' (Wolfe et al, 1987a) . Fatty acids are released at a rate in excess of their rate of oxidation. The non-oxidized fatty acids arè recycled' by being reesteri®ed back into triglyceride. If the reesteri®cation occurs in the liver, under normal circumstances the newly-formed triglycerides will be secreted into the blood in very low density lipoproteins (VLDL) so that the fat can be transported back to peripheral adipose tissue for storage. Fatty acids can also be directly taken up from plasma and reesteri®ed. Under normal conditions, about half of fatty acids released by lipolysis are reesteri®ed. In severely burned patients, this percentage is increased to 65% or more (Wolfe et al, 1987a) because lipolysis is stimulated to a greater extent than is fat oxidation. Consequently, there is a ®ve-fold increase in triglyceride-fatty acid recycling in burn injury (Wolfe et al, 1987a) . This indicates that there are far more endogenous fatty acids available as energy substrates than are required to meet energy demands.
The extent to which the high rate of triglyceride-fatty acid cycling is due to a de®ciency in fatty acid oxidation has not been assessed in critically ill patients. However, in a septic dog with responses similar to those of humans (Shaw & Wolfe, 1994) it was found that plasma FFA oxidation was increased above normal in the post-absorptive state (Wolfe et al, 1983) . Furthermore, the extent to which the oxidation of fatty acids derived from plasma VLDL-TG contributed to total energy production was increased in sepsis . These observations in the dog indicate there is no impairment in the ability to oxidize fatty acids during sepsis. On the other hand, the hyperglycemiaahyperinsulinemia that is often present, particularly during nutrient intake, may exert an inhibitory effect on fatty acid oxidation. In normal volunteers, when fatty acid concentration is maintained constant by the infusion of a lipid emulsion and heparin, the rate of fatty acid oxidation is determined by the availability of glucose. Therefore, when glucose and insulin are high, fatty acid oxidation is inhibited at the whole body level (Sidossis et al, 1996b) and both within the leg and splanchnic bed (Sidossis et al, 1998) . In contrast, in the setting of a constant rate of glucose uptake, changing the FFA concentration does not affect the rate of glucose oxidation (Wolfe et al, 1988b) . Taken together, these results indicate that the availability of glucose normally dictates substrate oxidation and that fat oxidation basically makes up the difference between glucose oxidation and the need for energy (Sidossis & Wolfe, 1996b) . Presuming the same relationship holds in patients, we would predict that the hyperglycemiaahyperinsulinemia that accompanies carbohydrate intake would limit fatty acid oxidation.
Considering that circulating fatty acids are available to a far greater extent than they are needed as substrates for energy, it would be predicted that exogenous fat would not substantially affect substrate metabolism. In fact, we found this to be the case in a study in which the contribution of exogenous fat to substrate metabolism was distinguished from the oxidation of endogenous fat by stable isotope tracer methodology (Goodenough & Wolfe, 1984) . In this study, about 70% of the fat component of energy metabolism could be accounted for by plasma FFA oxidation, even during the infusion of an exogenous lipid emulsion. Therefore, the exogenous lipid served to maintain peripheral lipid stores, rather than being directly used as an energy substrate. This study provided little metabolic rationale for the provision of exogenous fat as an energy substrate in severely stressed patients in whom lipolysis is stimulated and thus the availability of FFA is already high.
Insulin as an anabolic hormone
Although the topic of this paper is glucose and fat metabolism, it is pertinent to consider the anabolic action of insulin on protein, since carbohydrate intake stimulates the release of insulin. Furthermore, if exogenous insulin is given to promote anabolism, an increase in carbohydrate intake may be necessary to avoid hypoglycemia. Therefore, carbohydrate intake and insulin are intimately linked. The anabolic effect of insulin on muscle protein metabolism is well established in normal circumstances (Biolo et al, 1995) . In a recent study, the response to seven days of a high dose of insulin was studied in severely burned patients (Sakurai et al, 1995) . The insulin infusion was rapid enough to produce insulin concentrations suf®ciently high (greater than 500 mUaml) to elicit the maximal metabolic response. In each case, patients were studied in the fed state. Nonetheless, without exogenous insulin infusion, there was a negative muscle protein balance. Insulin was effective in eliminating the negative protein balance across the leg that existed before the insulin infusion. This was accomplished as a consequence of the stimulation of the rate of protein synthesis, which in turn was related to an increase in the inward transport of amino acids (as re¯ected by phenylalanine transport (Sakurai et al, 1995) . This result was consistent with an earlier study indicating the wholebody responsiveness of protein metabolism to the anabolic action of insulin was retained in both severely burned patients, as well as in patients with sepsis .
In the studies cited above, the anabolic action of insulin on protein metabolism was retained in both burned patients and in septic patients, even though the hypoglycemic action of insulin was impaired. The use of exogenous insulin infusion is therefore a potential therapeutic approach. However, exogenous insulin injection requires the simultaneous provision of glucose to avoid hypoglycemia. In the study described above in which patients were infused with insulin for seven days, the caloric intake during insulin infusion was more than twice the resting energy expenditure. Given the limitations in the maximal oxidation of exogenous glucose (Wolfe et al, 1980) , provision of so much excess carbohydrate presents potential concerns, including stimulation of hepatic fatty acid synthesis and excess carbon dioxide production, potentially contributing to increased PCO 2 . Regarding the latter point, no clinical problems were encountered during insulin infusion, including altered requirements for ventilatory support. Regarding the fate of nonoxidized glucose, it is important to consider the effect of insulin on the regional fate of ingested or infused glucose. Muscle and fat are the principal insulindependent tissues, meaning that the extent of glucose uptake in those tissues is determined largely by the prevailing insulin concentration. In contrast, hepatic glucose uptake is determined by the glucose concentration in the portal vein, and to a lesser extent, in the hepatic artery. Consequently, a greater proportion of an oral load of glucose will be taken up in the liver than if the same amount of glucose is infused intravenously. Therefore, when exogenous insulin is given, a greater proportion of infused, or ingested, glucose is taken up peripherally. Therefore, insulin infusion caused a greater than sevenfold increase in leg glucose uptake in the study described above (Sakurai et al, 1995) . Furthermore, the results of a recent study of chronic excess carbohydrate intake in healthy volunteers indicated that most fat synthesis from glucose occurred in the peripheral fat, rather than in the liver (Aarsland et al, 1996a) . In the short term, stimulation of fat synthesis in adipose tissue poses no problem to critically-ill patients. Therefore, these studies provide support for the use of exogenous insulin in critically ill patients.
Whereas the excess carbohydrate intake required to avoid hypoglycemia when maximal doses of insulin are given may not represent a major metabolic problem, provided the glucose concentrations are maintained low enough so that hepatic glucose uptake is not stimulated (below 120 mgadL), it is dif®cult to treat patients with such a high dose of insulin. Constant measurement of the blood glucose concentration is needed to avoid hyperglycemia, and the rate of carbohydrate intake may have to be frequently adjusted. However, a more recent study (Ferrando et al, 1999) reports that a lower dose of insulin (approximately 2.6 mUakgamin) increases the plasma insulin concentration suf®ciently (to approximately 240 mUa mL) to stimulate muscle protein synthesis, but no increase in caloric intake was required to avoid hypoglycemia. This is consistent with previous observations at the whole body level that even when there is a marked resistance to the hypoglycemic action of insulin, the effect of insulin on protein metabolism is retained.
Consequences of mismatching supply and utilization of energy substrates
Development of fatty in®ltration of the liver is a common observation in burned patients (Aarsland et al, 1996b) , as well as in other critically-ill patients (Wolfe et al, 1988b) . This has generally been presumed to be the consequence of de novo fatty acid synthesis, presumably from the exogenous glucose given as nutritional support. The basis for this presumption is that provision of hypercaloric amounts of glucose for several days results in a respiratory quotient Sepsis as a modulator of adaptation RR Wolfe greater than one (Wolfe et al, 1980) , indicating net fat synthesis, and it is thought that most fat synthesis in humans occurs in the liver. However, from the above discussion it is evident that in burn patients a large amount of FFA must be reesteri®ed under any nutritional condition due to the high rate of lipolysis, and the liver is a major site of this process. In a recent study the contributions of de novo synthesized fatty acids and plasma fatty acids to the production of hepatic triglycerides were distinguished using a new model relying on the mass isotopomer distribution analysis technique (Chinkes et al, 1996) . Patients were given several days pretreatment with nutrition support with non-protein calories coming almost exclusively from glucose in order to maximize the likelihood of de novo synthesized fatty acids contributing to hepatic TG formation. This approach should have not only maximized de novo synthesis of fatty acids, but also decreased the contribution of circulatory fatty acids to hepatic triglyceride production because of the suppressive effect on lipolysis of glucose infusion and the resulting insulin response (Miyoshi et al, 1988) . However, even in this circumstance created to maximize the contribution of de novo synthesized fatty acids to hepatic triglyceride, reesteri®ed fatty acids from plasma still comprised the majority of fatty acids incorporated into triglycerides in the liver (Aarsland et al, 1996b) . These results indicated that in fact it is unlikely that carbohydrate intake, per se, would be directly responsible for hepatic triglyceride accumulation in burn injury or in any other case. On the other hand, carbohydrate intake could increase hepatic triglyceride synthesis indirectly by inhibiting hepatic fatty acid oxidation. In normal subjects, hyperglycemiaahyperinsulinemia inhibits splanchnic FFA oxidation, but does not limit FFA oxidation (Sidossis et al, 1998) , meaning that the fatty acids are more ef®ciently channeled into triglyceride synthesis. This is the mechanism explaining hypertriglyceridemia during chronic hyperglycemia in otherwise unstressed individuals (Aarsland et al, 1996a) . However, it is more likely that the nature of the nutritional support is not particularly important in the development of fatty in®ltration of the liver in seriously ill patients. It has been reported that there was no relation between the type of nutritional support and the extent of fat in®ltration in the liver (Wolfe et al, 1988b) . Since the extent of increase in lipolysis in stressed patients is a function of the magnitude of sympathetic nervous system response (Wolfe et al, 1987b) , it is possible that there is a direct link between the degree of stress and the rate of hepatic triglyceride production, irrespective of the nature of nutritional support. It is also possible that neither FFA appearance or de novo synthesis of fatty acids is the cause of hepatic fat accumulation. In some physiological conditions, such as the response to exercise training, the rate of hepatic reesteri®cation of fatty acids increases several fold, yet hepatic fat accumulation does not occur (Romijn et al, 1993) . Therefore, it is possible that hepatic fat accumulation in critical illness is due to a de®ciency in secretion, unrelated to the rate of hepatic triglyceride production. In any event, there are no data speci®cally linking the rate of hepatic triglyceride production in critically ill patients to the rate of nutrient intake. The potential pulmonary complications stemming from excessive carbohydrate ingestion are well-established (Askanazi et al, 1981) . This problem is pertinent for patients on ventilators, because net fat synthesis from ingestion of carbohydrate results in an RQ greater than one, and the excess CO 2 production may prolong the need for ventilatory assistance. However, this really is more of a problem of excessive caloric intake than one speci®cally linked to carbohydrate. A large excess of glucose intake beyond caloric requirements is needed before the RQ exceeds one, and there is no rationale to justify a large caloric overload to critically ill patients.
